Navigation Links
Cardiome kündigt Anwesenheit auf dem ESC Congress 2013 in Amsterdam an
Date:8/30/2013

r anderen externen Kostenträgern für Produkte und verwandte Behandlungen; Nebenwirkungen oder unerwartete Verzögerungen im vorklinischen und klinischen Produktentwicklungsprozess; nachteilige Ergebnisse bezüglich der Sicherheit und/oder Wirksamkeit unserer Produkte oder von Produkten; die Entscheidungen, und der Zeitplan von Entscheidungen, die von Gesundheitsbehörden in Bezug auf die Zulassung unserer Technologie und Produkten getroffen werden; der Bedarf nach substanziellen Finanzmitteln für die Ausweitung unserer kommerziellen Aktivitäten; und andere Faktoren, die unsere Performance beeinflussen. Darüber hinaus unterliegt unser Geschäft bestimmten betrieblichen Risiken, welche dazu führen können, dass sich durch die zukunftsbezogenen Aussagen in dieser Veröffentlichung ausgedrückten beziehungsweise implizierten Ergebnisse wesentlich von unseren tatsächlichen Ergebnisse unterscheiden. Zu diesen betrieblichen Risiken gehören: unsere Fähigkeit, qualifiziertes Personal anzuziehen und zu halten; unsere Fähigkeit, vorklinische Studien und die klinische Entwicklung unserer Produkte erfolgreich abzuschließen; Änderungen in unserer Geschäftsstrategie beziehungsweise unserer Entwicklungspläne; Belange im Bereich geistiges Eigentum, unter anderem die Unvorhersehbarkeit oder der Verlust unseres Patentschutzes durch die Infragestellung unserer Patente durch Drittparteien; die Marktakzeptanz unserer Technologie und unserer Produkte; unsere Fähigkeit zur erfolgreichen Herstellung, Vermarktung und dem Verkauf unserer Produkte; der Verfügbarkeit von Kapital zur Finanzierung unserer Aktivitäten; und andere Faktoren, die detailliert in unseren Einreichungen bei der Securities and Exchange Commission dargelegt sind und unter http://www.sec.gov und bei den für den Wertpapierhandel zuständigen A
'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CardioMEMS Named as a Finalist for Intel Innovation Award
2. CardioMEMS, Inc. wins 2012 Intel Innovation Award
3. CardioMEMS Vice President - Information Systems, Richard Powers, and Chairman of the Board, John Huntz, Selected as Finalists for Prestigious Awards
4. CardioMEMS CFO, Daniel H. Bauer, Honored with a CFO of the Year Award by the Atlanta Business Chronicle
5. Cardiome anuncia su presencia en el Congreso ESC 2013 en Ámsterdam
6. GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
7. Simbionix kündigt Lizenzvertrag für chirurgische Videos an
8. Blue Belt Technologies kündigt Gründung eines wissenschaftlichen Beirats für Hüfteingriffe zur Bestimmung neuer Anwendungsgebiete von NavioPFS bei femoro-acetabulärem Impingement an
9. Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an
10. CryoLife kündigt erste Implantation des HeRO Transplantats in Europa an
11. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  HyGreen, Inc., a leader in hand hygiene monitoring, ... Medical, a subsidiary of Ascendis Health Limited, in ... year, hundreds of millions of patients around the world ... transmitted from patient to patient via the unwashed hands ...
(Date:1/23/2015)... 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC ...  filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. ... an update for shareholders detailing why a "YES" vote to ... Dear Shareholders, As we reflect upon the 2014 ...
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 The federal ... in the U.S. District Court, Southern District of West Virginia ... Inc. in that proceeding’s first bellwether trial. In an Order ... a new trial after finding that C.R. Bard had not ...
(Date:1/22/2015)... has released a new blog post explaining the main features ... , Auto insurance quotes help many drivers find the best ... call an agent or visit an agency for price information. ... http://autocarinsurancebest.com/ . , Every business who relies heavily on ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... plant research centre at University of Newcastle upon ... Research found that green and black tea inhibit ... on Alzheimer's Disease. Alzheimer's is a form of ... people worldwide., ,According to the journal, tea ...
... findings of a recent study researchers say that the circadian ... , can significantly impact lung function and help determine peak ... ,During the study changes in lung function between 8:00 a.m. ... study, which tracked 4,835 patients undergoing breathing tests at various ...
... one of the leading causes of disability and death in ... the best approach. Obesity in middle-aged men can have a ... life, according to a new study. ,7,402 healthy men ... 28 years. Fatal and non-fatal incidences of stroke were recorded ...
... New research shows that sleep disorders may be linked ... ADD ), // neuromuscular conditions, and psychiatric problems. ... patients with sleep apnea also had ADD. Results also ... insomnia. Further testing showed some of these patients also ...
... should probably be tested to see if they carry ... according to findings of a recent study. Helicobacter pylori ... been linked to stomach cancer. However researchers are baffled ... bypass surgery a weight loss operation in which food ...
... interferon are found to protect people with early stages of ... followed up on a previous study which showed that beta ... early evidence of MS and found people who have the ... medication had their brain tissue decline on average by 1.18 ...
Cached Medicine News:
... Model 6495 Bipolar Coaxial Temporary Pacing Lead ... bipolar technology based on the sensing and ... Unipolar Temporary Pacing Lead., ,The Streamline Temporary ... temporary sensing and pacing during and after ...
... of temporary sensing and pacing leads. Our ... temporary pacing leads and improved upon the ... and less traumatic to heart tissue. , ... to provide consistent temporary sensing and pacing ...
... device was designed specifically to obviate the ... The eNcloseII device can provide the surgeon ... better hemodynamics as compared to partial occlusion ... suggested that complete or partial clamping of ...
... Carpentier-Edwards Classic annuloplasty rings have ... choice for more than 30 ... restore the anatomical size and ... to help prevent recurrent dilatation. ...
Medicine Products: